Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: Tolerability, efficacy, and changes in the progenitor cell compartment

Annals of Hematology

Volumn 78, Issue 7, 1999, Pages 299-304

  Meidlinger, P ^a   Knobl P ^a   Jager U ^a   Gisslinger, H ^a   Pabinger, I ^a   Weltermann, A ^a   Lechner, K ^a   Geissler, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aplastic anemia; Erythroid myeloid progenitor cells; Immunosuppressive therapy; rhG CSF

Indexed keywords

CYCLOSPORIN; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; CAUSE OF DEATH; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMATION; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; PRIORITY JOURNAL; REMISSION; RETICULOCYTE COUNT; SEPTICEMIA; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE TRANSFUSION;

ADULT; AGED; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PLATELET COUNT; RETICULOCYTE COUNT; THERAPEUTIC EQUIVALENCY;

EID: 0344132577     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050519     Document Type: Article

References (28)

1. + colony-forming cell types in blood and marrow of baboons. Blood 80:920-927
2. Bacigalupo A, Chaple M, Hows J, Van Lint MT, McCann S, Milligan D, Chessells J, Goldstone AH, Ottolander J, van't Veer ET, den Ostendorf GJ, Comotti B, Coser P, Broccia G, Bosi A, Locasciulli A, Catalane L, Battista R, Arcese W, Carotenuto M, Marmont AM, Gordon Smith EC (1993) Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (Mpred) with or without androgens: a randomized trial from the EBMT SAA working party. Br J Haematol 83:145-151
3. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G, Coser P, Iacopino P, van Lint MT, Gluckman E (1995) Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 85:1348-1353
4. Brodsky RA, Sensenbrenner LL, Jones RJ (1996) Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood 87:491-494
5. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L (1995) Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283-287
6. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53:504-514
7. Champlin R, Ho W, Gale RP (1983) Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 308:113-118
8. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy J (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164-170
9. De Planque MM, Bacigalupo A, Würsch A, Hows JM, Devergie A, Frickhoven N, Brand A, Nissen C (1989) Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Br J Hematol 73:121-126
10. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324:1297-1304
11. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414-1422
12. Geissler K, Valent P, Mayer P, Liehl E, Hinterberger W, Lechner K, Bettelheim P (1990) Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates - synergism with recombinant human granulocyte/macrophage colony-stimulating factor. Blood 75:2305-2310
13. Geissler K, Forstinger C, Kahls P, Knöbl P, Kier P, Kyrle P, Lechner K (1992) Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia. Ann Intern Med 117:223-225
14. Hinterberger W, Adolf G, Aichinger G, Dudczak R, Geissler K, Höcker P, Huber C, Kahls P, Knapp W, Köller U, Lechner K, Volc-Platzer B (1988) Further evidence for lymphokine overproduction in severe aplastic anemia. Blood 72:266-272
15. Hoffman R, Zanjani ED, Lutton JD, Zalusky R, Wasserman LR (1977) Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. New Engl J Med 296:10-13
16. Imamura M, Kobayashi M, Kobayashi S, Yoshida K, Mikuni C, Ishikawa Y, Mastumoto S, Sakamaki S, Niitsu Y, Hinoda Y, Yachi A, Kudoh T, Chiba S, Kasai M, Oka T, Okuno A, Maekawa I, Sakurada K, Miyazaki T (1995) Combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in aplastic anemia. Am J Hematol 48:29-33
17. Kojima S (1996) Use of hematopoietic growth factors for treatment of aplastic anemia. Bone Marrow Transplant 18 [Suppl 3]: S36-38
18. Leonard EM, Raefsky E, Griffith P, Kimball J, Nienhuis AW, Young NS (1989) Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol 72:278-284
19. Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I, McKendrick J, Toner G, Bradstock K, Lieschke M, Cruickshank S, Tomita DK, Hoffmann EW, Fox RM, Morstyn G (1994) Filgrastim in patients with chemotherapy-induced febrile neutropenia. Ann Intern Med 121:492-501
20. Marmont AM, Bacigalupo A, Van Lint MT, et al (1984) Treatment of severe aplastic anemia with high-dose methylprednisolone and antilymphocyte globulin. Prog Clin Biol Res 148:271-287
21. Ohno R, Tomonaga M, Kobayashi T, Kanamaru A, Shirakawa S, Masaoka T, Omine M, Oh H, Nomura T, Sakai Y, Hirano M, Yokomaku S, Nakayama S, Yoshida Y, Miura AB, Morishima Y, Dohy H, Niho Y, Hamajima N, Takaku F (1990) Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 323:871-877
22. Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE, Nimer SD (1995) Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood 85:283-290
23. Pettengell R, Gurney H, Radford JA, Deakin DP, James R, Wilkinson PM, Kane K, Bentley J, Crowther D (1992) Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood 80:1430-1436
24. Podesta M, Piaggio G, Frassoni F, Pitto A, Zikos P, Sessarego M, Abate M, Van Lint MT, Berisso G, Bacigalupo A (1998) The assessment of the hematopoietic reservoir after immunosuppressive therapy or bone marrow transplantation in severe aplastic anemia. Blood 91:1959-1965
25. Rosenfeld SJ, Kimball J, Vining D, Young NS (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe aquired aplastic anemia. Blood 85:3058-3065
26. Speck B, Gluckman E, Haak HL, Van Rood JJ (1977) Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet 2:1145-1148
27. Young NS, Maciejewski J (1997) Mechanisms of disease: the pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365-1372
28. Zoumbos NC, Gascon P, Djeu JY, Young NS (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A 82:188-192